miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways

Xiaoyan Sun(Huazhong University of Science and Technology), Juan Tao(Union Hospital)
Oncotarget
July 18, 2016
Cited by 100


Related Papers